Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially impacting only one side of the body. Although it first manifests through motor ...

Designed for advanced Parkinson’s with poorly controlled motor fluctuations, the infusion delivers steadier levodopa exposure than pills via continuous subcutaneous dosing.

Current smokers had less incident Parkinson's, but higher mortality risk ...

Parkinson's disease is the second most common neurodegenerative disease, affecting over 10 million people worldwide. Some forms of Parkinson's disease are characterized by an inability of cells to ...

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

DEAR DR. ROACH: I’m a 65-year-old and otherwise healthy male. After spending the past five years believing that my trembling hands were the result of essential tremor, a second DaT (dopamine ...

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

Parkinson’s disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) ...